vimarsana.com

Page 11 - கெந்நெடீ ஶ்ரைவர் தேசிய நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MIL-OSI USA: NIH-funded research team develops language test for people with Down syndrome

Media Advisory What A research team funded by the National Institutes of Health have developed a test to evaluate the expressive language skills of people with Down syndrome, a condition resulting from an extra copy or piece of chromosome 21. Expressive language is the use of words to convey meaning to others. Language delays are common in people with Down syndrome, and the study authors believe their test provides a more effective way to evaluate prospective language interventions, compared to current evaluation methods. The study was conducted by Angela Thurman, Ph.D., of the University of California, Davis, and appears in the

NIH funds study to evaluate remdesivir for COVID-19 in pregnancy

HIN A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who have been prescribed the drug to treat COVID-19. The study, which will be conducted at 17 sites in the continental United States and Puerto Rico, aims to determine how pregnant women metabolize the drug and whether there are any potential side effects. “Pregnant women with COVID-19 are at high risk for hospitalization, for intensive care admission and for needing ventilator support,” said Diana W. Bianchi, M.D., director of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). “There is an urgent need to identify effective treatments for this population and to determine whether drugs prescribed for other adults are appropriate for use in pregnancy.”

Severe COVID-19 in pregnancy associated with preterm birth, other complications

NIH-funded study also suggests mother-to-infant transmission appears to be rare. What Pregnant women who experienced severe symptoms of COVID-19 had a higher risk of complications during and after pregnancy, according to preliminary findings from a National Institutes of Health study. Compared to COVID-19 patients without symptoms, those with severe symptoms were at higher risk for cesarean delivery, postpartum hemorrhage, hypertensive disorders of pregnancy and preterm birth. The study was led by Torri Metz, M.D., of University of Utah Health, Salt Lake City, and Rebecca Clifton, Ph.D., of the Milken Institute School of Public Health at the George Washington University, Washington, D.C. An abstract of the study will be presented today at the Society for Maternal-Fetal Medicine’s virtual annual meeting.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.